Time: Fri Aug 22 13:27:05 1997
	by usr03.primenet.com (8.8.5/8.8.5) with SMTP id HAA13913;
	Fri, 22 Aug 1997 07:20:17 -0700 (MST)
Date: Fri, 22 Aug 1997 07:18:52 -0700
To: (Recipient list suppressed)
From: Paul Andrew Mitchell [address in tool bar]
Subject: SLS: Blood Feud (2 of 2) (fwd)


<snip>
>
>Subject: Blood Feud
>
>in the Sherbrooke courthouse in 1989.  He seemed doomed to the
>hinterlands of science.
>
>        I first traveled to Rock Forest in January, 1992, taking with me
>a
>friend who would be termed a high risk for cancer:  His mother and one
>brother have died from the disease; his father and another brother are
>currently undergoing treatment for it.
>
>        An unlikely spot for a revolution in science, from the outside
>Naessens' laboratory looked like any other summer cottage.  At -18 C,
>however, it was not summer, and the snow crunched and squeaked as we
>walked towards the second of two cottages in the compound.
>
>        An informal seminar for two American MDs was being held that
>day, and
>we were invited to attend.  Two guard puppies yelped, and tried to lick
>our faces, as Daniel Sdicu, one of Naessens' four stepchildren, opened
>the door.
>
>        Inside in a room bare but for a long table and chairs, Naessens
>stood
>to greet us.  Tall and imposing -- even his stepchildren refer to him as
>
>"Monsieur Naessens" -- he was formally polite.  Introduced to the two
>doctors from Vermont, we sat quietly and listened.
>
>        One of the doctors, Bradford Weeks, interpreted Naessens' French
>for
>the other, a gaunt, worried-looking man.  Part of the discussions in
>progress involved a new modified version of the somatoscope that
>Naessens calls an "ultramicroscopic condenser," which -- attached to any
>
>optical microscope and for a modest $3,000 -- will enable a doctor or
>scientist to perform basic aspects of blood analysis according to the
>somatid theory.  The rest covered what was to me by now familiar ground,
>
>with Naessens acting the strict but fair teacher.
>
>        Then we crunched fifty yards through the snow to the older, main
>
>cottage.  Inside this neat and tiny house -- clearly Naessens' home --
>we removed our boots, were given woolen slippers to wear, and were shown
>
>into a sitting room whose most prominent feature was an illuminated
>shrine to the Virgin Mary.
>
>        In one corner of this otherwise ordinary room a staircase led
>down.  At
>the foot was a real if somewhat antique laboratory:  Test tubes,
>retorts, specimen tubes, the lot.  To one side, dominating everything,
>was the somatoscope.  Looking like a cross between an ordinary large
>optical microscope and the inside of an old television set, the
>revolution in microscopy was definitely complicated.
>
>        A metal box labeled Helium-Neon Laser was attached to one side
>and a
>small video camera to the top; a web of wires ran to other contraptions
>below and behind it; there was a computer to the left, and some
>high-tech electronics connected to a monitor and Super VHS machine on
>the right.
>
>        Wandering down the long narrow room, with its panoramic views of
>the
>Magog ice scape, I came across a strange fleshy pink blob under clear
>viscous liquid in a sealed jar, like something left over from a David
>Cronenberg movie.
>
>        I asked the worried-looking Vermont doctor what it was.  He
>peered
>closely at the slimy bolus and eventually replied, "I don't know, but
>whatever it is it's alive."  Naessens cheerfully explained that the blob
>
>had started life as a bit of muscle tissue he'd taken from a living rat,
>
>injected with a concentration of pure rat somatids, sealed in a
>sterilized glass jar under vacuum, and then put on his lab windowsill
>back in 1978.  "Ever since," he added, "the cells have continued to
>grow."  "Great," the doctor laughed uneasily.  "Grow your own
>hamburger."
>        What everyone was really here for, however, was to see his own
>blood
>under the unique microscope.  First taking a sample from Dr. Weeks --
>washing his hands, sterilizing the doctor's finger with alcohol, then
>taking the crimson pinprick onto a slide and covering it with a sliver
>of glass -- Naessens moved to his extraordinary device, flipping
>switches, positioning; the slide, peering through the eyepieces.
>
>        After focusing, he flipped another switch and the nearby monitor
>
>suddenly revealed what he was seeing.  Tiny star-like dots pulsed and
>danced around brilliant circles that were, the biologist explained, red
>corpuscles.  An awed silence followed, then gasps of amazement -- there
>was a singular beauty to this spectacle.
>
>        Carefully shifting the slide around -- the tiny pinprick of
>blood at
>20,000 X like a hot tub full of stars -- Naessens explained the various
>forms we saw in normal and healthy living blood, untreated, unstained.
>
>        Then it was the worried doctor's turn.  There was the wait as
>the slide
>was prepared.  But this time the blood looked distinctly different:  The
>
>level of pulsing somatids seemed greatly reduced, and the later forms of
>
>the sixteen-stage cycle were clearly present, some great twisted shapes,
>
>bars, and curious blobs with filaments.
>
>        "This is so strange," the doctor murmured, "seeing your own
>blood.  I
>mean your own blood alive."  Naessens scanned the sample more thoroughly
>
>than he had Dr. Week's.  He asked if the doctor had been suffering from
>fatigue (he had) and the doctor in turn asked a few questions about AIDS
>
>that seemed to indicate the source of his worry.
>
>        Avoiding any explicit diagnosis, Naessens told him that there
>was
>definitely a stress on his immune system and that he should cut down his
>
>workload, rest more, and put himself on a strict diet -- no red meat, no
>
>dairy products, lots of fresh fruit and vegetables.  Then get his blood
>checked again in a month or so.
>
>        The man's mounting gloom was contagious; it also seemed a rather
>
>private moment to have strangers present, so my friend and I left,
>arranging to come back the next day.  Neither of us could shake the
>image of that doctor faced with a picture of his mortality.
>
>        The next day it was my blood Naessens looked at first.  With
>sweaty
>palms and a knotted heart, I waited until the video monitor was flipped
>on, seeing that universe of stars and red corpuscles like jostling
>balloons.  Naessens moved the slide, pointing out forms, each one of
>which had me asking if that meant cancer.
>
>        But no, all was as it should be.  Beyond an apparent indication
>of iron
>deficiency Naessens saw nothing amiss.  Once I was able to relax, there
>was something inexpressibly thrilling about the play of the elements in
>living blood my blood -- something fundamental.
>
>        But the mood was shattered.  My friend's blood appeared next on
>the
>monitor.  The red corpuscles seemed more frail, less defined.  And
>stretching across the screen, coiled and serpent-like, was the last form
>
>in the sixteen-stage cycle -- the "thallus," the discarded shell that
>has expelled new somatids.  As Naessens moved the slide, indicating
>other forms from the complete cycle, my friend paced the lab in shock
>and fear.
>
>        Naessens continued to scan, pointing out forms, one of which --
>a
>circular shape with waving snake-like protrusions that he termed the
>Medusa head -- seemed busy surrounding "intruders" or seemed at least
>very busy.  "Ask your most eminent hematologists what that is ,"
>Naessens told me.  "They cannot answer."
>
>        When my friend emerged from a prolonged and silent spell in the
>washroom, Naessens assured him that all this activity showed that his
>immune system was fighting, certainly, but in good shape.  The somatid
>level was still relatively high, and the presence of the Medusa heads
>indicated an aggressive response to some form of stress.
>
>        My friend then told Naessens his family history, but the
>biologist
>still resisted any diagnosis, and advised him to follow the same
>regiment of diet and relaxation he'd recommended for the doctor the day
>before.
>
>        Augustin Roy had accused Naessens of furtive and covert work but
>
>Naessens was hardly secretive, his lab and files patently open to anyone
>
>who was interested.  No-one was getting rich here either.  When I asked
>if he's supplied 714-X free to anyone willing to perform standard animal
>
>tests he immediately said yes, providing the tests were carried out
>according to his protocols, the compound injected intralymphatically and
>
>not into the tumors or the blood.
>
>        In Canada, because of his problems, Naessens was giving it away
>to any
>physician who asked for it through official channels.  As of October,
>1992, 210 MDs across the country were administering it to patients,
>admittedly on compassionate grounds, in most cases, and at their
>patients' request.
>
>        In retrospect, what impressed me most during this first
>exploratory
>visit was the devotion of Naessens' stepchildren.  Only in Rock Forest
>did I learn that their mother, Francoise, had died of a rare fungal
>infection just four months earlier.
>
>        (It was one of those horrible ironies that Naessens, who had
>helped so
>many people in endgame situations, had been unable to help his wife.)
>Her children's faith in their late mother's strange and brilliant
>husband seemed absolute.  That two of his stepchildren had degrees in
>biology said more for Naessens than any other fact of his life.
>
>        Shortly after we left, my friend's anxiety gave way to rage.
>How could
>I have subjected him to this?  How could Naessens be so irresponsible as
>
>to put anyone through such an ordeal?  Before we drove home we went back
>
>to Naessens again, who went out of his way to reassure my friend that
>the apparent stress affecting his bodily system could easily be
>corrected at such an early stage.  Hearing, once again, about the diet
>he should follow, my friend just groaned, "But what's left to eat?"
>
>        Never did a man follow a diet so religiously as did my friend
>over the
>next three months.  And what I did, almost as religiously, was take the
>video tape of our blood and a description of Naessens' theories to
>anyone I thought might help me judge them.
>
>        Calling Tak Mak, head of cellular and molecular biology at the
>Ontario
>Cancer Institute, and one of this country's most eminent cancer
>researchers, I was surprised to find him unwilling even to hear an
>account of Naessens' work.  "It doesn't sound kosher," was all he said,
>adding that blood wasn't really his field anyway.
>
>        He referred me to a leading hematologist at the OCI, Dr. Mark
>Minden,
>who reluctantly agreed to meet me and view the video tape shot through
>the somatoscope.  Arriving early, I found Minden rummaging around his
>tiny cluttered office in jeans and sneakers.  He claimed to have
>forgotten the appointment; he then left the room on the lookout, he
>said, for a VCR.
>
>        He came back half an hour later, without the equipment and
>patently
>hoping that I'd be gone.  Instead I suggested that the nation's finest
>cancer-research hospital might have an audiovisual department.
>Muttering about grant applications that needed his urgent attention, he
>finally led me up many stairs and down many corridors to a cupboard
>possessing a monitor and a VCR into which I plugged my tape.
>
>        "What were the somatids?", I asked.  "Platelets or proteins in
>Brownian
>motion", he replied, but I could see that something on the tape
>fascinated him.  Did he ever study live blood?  No -- or very rarely --
>was the answer.  The electron microscopes and ordinary optical
>microscopes he used required fixed and stained blood.
>
>        To prevent his running out of the cupboard -- he hopped from
>foot to
>foot like an athlete about to make the hundred -yard dash -- I
>fast-forwarded to my friend's blood, asking him about the difference
>between the samples.  Well, he said, this blood was obviously in an
>advanced state of clotting.
>
>        When I assured him that the sample had been taken under the same
>
>circumstances as my own, he pointed out that blood clots at different
>rates, though he'd have to look at it under the electron microscope to
>be sure of what he was seeing.  What were the large coiled forms that
>Naessens identified as the final stage in the somatid cycle?  Fibron, he
>
>said, a protein that forms when blood begins to clot.  Why was there
>none of it in my blood sample, even after ten minutes of watching?  He
>had no answer to that.
>
>        What Minden couldn't attribute to clotting he called
>"artifacts"-- a
>scientific way of saying "bits of stuff."  The term in microscopy also
>implies structures that are accidentally created in the human handling
>of the sample on the slide.  We looked at the Medusa head -- the form
>Naessens had told me to show to a top hematologist.
>
>        He would have to stain and fix it to see if it had a nucleus,
>before he
>could comment; it was the only artifact that seemed to shake his
>certainty. I then showed him a diagram of Naessens' somatid cycle, which
>
>he dismissed outright.  As I left Minden I thought, well, at least when
>pushed into a closet he was willing to look.]
>
>        It took a while to find a doctor with an orthodox scientific
>background
>who was willing to stand up for Naessens.  Dr. Dietmar Schildwaechter is
>
>an MD and medical Ph.D. who was a longtime faculty member of the
>University of Pennsylvania School of Medicine, the oldest medical school
>
>in the U.S.
>
>        One of his special fields was early cancer detection; he left
>the
>university to take over the Ratzenburg Klinik fur medizinische
>Rehabilitation, one of the world's most advanced cancer-rehabilitation
>centres, in his homeland, Germany.  He now operates an office in the
>District of Columbia consulting in preventive medicine and oncology
>while continuing to care for patients in Europe.
>
>        Schildwaechter came across Gaston Naessens in 1990 after
>discovering
>they were both treating the same "celebrity" patient, a "relative of
>George Bush".  In 1986 the woman was diagnosed with "one of the most
>devastating cancers: an oat-cell carcinoma of the lung that had
>metastasized to the brain, the adrenal gland, and the tissue between the
>
>lungs," says Schildwaechter.
>
>        She and her husband had investigated the available treatments
>and
>discovered that for such a cancer there was no statistical survival
>after three years, though the rare individual did survive.  Electing to
>go to the leading clinic in Bonn, she received chemotherapy, radiation,
>and various other primary treatments that brought the disease under
>control.
>
>        Then she was referred to Schildwaechter, who kept her on a
>maintenance
>program, employing frequent cancer and immune-system profile tests
>developed by Dr. Emile Schandl, a Hungarian-born research biochemist and
>
>geneticist who lives in Florida.
>
>        The monitoring-test results - immune parameters, complete blood
>count,
>differential count, blood chemistry, and so on - were computerized,
>giving, over the years, some of the most exact documentation of the
>results of the treatment of this illness that exist.  "At the end of
>1989," Schildwaechter says, "her blood sample arrived and its values had
>
>changed remarkably.
>
>        The immune-system values had improved drastically.  We had
>always seen
>a slight activity from her cancer - which we'd kept in remission - now
>it was down to zero.  There were also two other markers that could not
>be done during this testing because, as our lab said, of something like
>chemical interference in her metabolism."
>
>        Schildwaechter called the couple to find out if something had
>been
>going on and found out that they had visited Naessens in Quebec, where
>the man had been taught how to give his wife injections of 714-X.  "They
>
>did not want to tell me because they thought I might not approve."  They
>
>needn't have worried.
>
>        Schildwaechter finally met Naessens at a seminar held at
>Sherbrooke in
>1991, and he unreservedly accepted Naessen's theory.  At medical school
>in Europe he'd learned about Bechamp and others "basically excluded from
>
>medical schools over here.  We were prepared for something like this,"
>he says.  "I knew there was something in the blood we'd not been able to
>
>diagnose, and I realized that Naessens had discovered and identified
>what others had only partially seen."
>
>        The resistance to Naessen's work from orthodox practitioners was
>only
>to be expected.  Schildwaechter himself had been "a totally orthodox,
>tunnel-vision MD who didn't want to look at anything out of the
>mainstream" when he had been at the University of Pennsylvania.  But
>then as he practiced he had begun to feel increasingly frustrated with
>the limits of his profession: "I had the most modern hospital, I could
>purchase the best equipment, yet I was still unable to monitor what I
>wanted."
>
>        In his spare time Schildwaechter traveled the world visiting
>medical
>centres and studying their techniques for monitoring blood, finding that
>
>none of them, from Britain to the Philippines, had the specificity and
>sensitivity that he required.  "I could not in all conscience tell my
>patients that they were free of cancer after a monitoring test that was
>only sixty-five-per-cent accurate."
>
>        Then he met Schandl and, in a sense, defected from regular
>medicine:
>"Colleagues I had worked with for years were not even willing to discuss
>
>this stuff, even though Schandl was a leading biochemist and his test
>results were couched in all the proper forms."  In Schildwaechter's
>view, his colleagues' excuse for dismissing Schandl's testing was that
>it was too complicated and impractical for ordinary labs to achieve.
>
>        The real reason, he believes, was that Schandl's tests could
>document
>the workings of alternative therapies that regular medicine had long
>dismissed and violently resisted.
>
>        The future of medicine in Schildwaechter's eyes lies in
>prevention, and
>the essence of prevention is a greater understanding of the workings of
>the immune system and the development of methods to detect telltale
>signs of imbalance long before symptoms appear.  Combining, as he now
>can do, Schandl's tests with Naessen's somatoscopic monitoring, and
>something known as cell-milieu medicine - which determines the patient's
>
>exact needs for trace elements, amino acids, and vitamins.
>
>        Schildwaechter claims tremendous success with his German
>practice in
>detecting and correcting imbalances that would lead to degenerative
>diseases.  (He hesitates to practice in the U.S. for fear of
>Naessens-style prosecutions.)  "Cancer," he announced with absolute
>conviction, "has become a truly preventable disease if we would only
>employ these blood tests.
>
>        "The number-one cancer today is breast cancer, so we tell women
>to have
>mammograms after forty.  But regardless of how modern the equipment,
>there is still a high false-negative ratio and by the time the mammogram
>
>detects something, we've lost two years during which we could have
>prevented the cancer if the somatoscopic blood tests had been used."
>
>
>        Naessen's day is coming, insists Schildwaechter: "A number of
>oncologists are impressed with his work, even if they won't admit it at
>the moment."  He sighs, and adds, "Szent-Gyorgyi, the discoverer of
>ascorbic acid and one of the great Novel laureates, remarked that
>whenever you pioneer something you first have to realize you may be
>called a quack.  But the Establishment will check you out, and if they
>find your discovery useful it will be accepted through the 'back door' -
>
>certainly without giving credit to the pioneer."
>
>        After three months' effort I did find two cautiously curious
>souls who
>were willing to look at the material through the back door and very much
>
>off the record.  Even more off the record, they described Naessen's work
>
>as interesting, but hesitated about coming to Rock Forest with me to see
>
>the somatoscope in action.
>
>        Finally I found a young microbiologist, Jacqueline Conant, then
>working
>as an associate scientist with the Robert Wood Johnson Pharmaceutical
>Research Institute in Toronto, who was intrigued (and professionally
>brave) enough to make the trip with me - and one very nervous friend
>heading for his second appointment with his own blood.
>
>        The moment Naessens had drawn the blood in question and turned
>to slide
>it into the jaws of the somatoscope, that friend was heading up the
>stairs.  Naessens flipped on the monitor, revealing a vastly improved
>picture.  He laughed and shouted, "C'est meilleur!" calling my friend
>back.
>
>        The full cycle of somatids was no longer evident, and the red
>corpuscles seemed more defined, more robust.  The fast-clotting blood,
>as Dr. Minden had described it, had changed its nature in three months.
>
>        Next, Naessens showed us a video tape of blood from a patient
>with very
>advanced cancer.  If normal blood had a sparkling beauty to it, this
>murky broth of filaments and tendrils had something deeply depressing
>about it.  All the sixteen stages in the somatidian pleomorphic cycle
>were clearly visible, floating like wreckage in the blood.  I couldn't
>see anything resembling red corpuscles and asked Naessens if this were
>so.  He pointed them out - bubbles filled with grit, their edges jagged
>filaments.
>
>        Then Naessens played a tape of the same patient's blood after
>three
>months' treatment with 714-X; after six months and a year.  The progress
>
>was clear and dramatic.  From what looked like Kitts's last cough, the
>final tape revealed that bright dancing universe I'd come to recognize
>as life and health.  My friend was cheered, more at seeing what
>diabolically cancerous blood looked like than at this unknown patient's
>restoration to health.
>
>        Jacqueline Conant had looked at everything with obvious
>fascination,
>asking many questions in tolerable French, but it was only on the way
>back home that I was able to find out what had been going on in her
>mind.
>
>        "It was like entering the last century going down there," she
>said.
>"It reminded me of Banting and Best's lab at the U. of T.  Then in the
>middle of it all, there's this feat of high-tech engineering through
>which he is able to make some truly remarkable observations."  But what
>did she think he was seeing?
>
>        "It's never been possible to see these particular entities
>before - and
>I call them entities because they do appear to be living.  What's their
>nature?" she asked.  "They could possibly be fragments of genetic
>material, all right, but what exactly is their biochemical structure?"
>
>        One of the things Naessens had shown her was an
>electron-microscope
>photograph of a sectioned somatid taken at 140,000 X; it resembled
>something Norval Morrisseau could have painted.  "I've never seen
>anything like it," she said, choosing her words with great care.  "I
>certainly didn't recognize it to be of viral origin.  It had definite
>structure, not structure as we normally know it, with a nucleus.  But,
>there was definite order to this particular structure."
>
>        Could it be, as Naessens maintained, a precursor to DNA?
>
>        After a long silence, Conant replied, "It is conceivable.  It's
>the
>particular building blocks of DNA that one has never yet been able to
>visualize.  In the electron microscope we've seen certain genetic
>fragments, chromosomes - the structures are fairly well elucidated."
>
>        A mighty pause.  "I have trouble with that term precursor, but I
>
>suppose, yes, it is conceivable."  Then, with passion: "There are so
>many tools around today that we would be able to elucidate a lot of
>Naessen's work, and yet the exciting thing for me is the extraordinary
>power of that particular microscope."
>
>        For microbiologists such as herself, she said, "it would
>certainly
>permit better patient management and therapeutic monitoring.  There are
>really all kinds of exciting applications for such a device both
>diagnostically and academically."
>
>        She paused again, and frowned thoughtfully.  "He was certainly
>able to
>show that many of the various examples of forms in the blood are quite
>disease-specific."  Naessens had shown her still photographs of somatid
>forms in the blood of AIDS, cancer, and multiple-sclerosis patients.
>
>        I told her Dr. Minden had described most of the forms as
>artifacts, and
>asked if the term did mean "bits of stuff."  She laughed and said it
>did.  But where did the stuff come from, I wondered, and why was there
>such a regular pattern in its forms?  Could it all be the result of
>human handling of the samples?
>
>        She looked at me, gauging how far she wanted to go in her
>answer, and
>then, apparently, decided to jump: "There was very little manipulation
>between taking the blood, making the slide, and then viewing it.  That's
>
>why there has to be something in it, and it certainly warrants further
>study.  But it's so foreign to the accepted dogma, you know, that it's
>going to be a hard sell."
>
>        Perhaps Naessens will live long enough to see a front-door
>vindication
>of his life's work.  In 1990, after receiving the positive results of
>non toxicity tests, Health and Welfare Canada agreed that 714-X could be
>
>supplied by Naessens to doctors whose patients were suffering from
>terminal cancer.  Doctors have to apply to Ottawa, where authorities may
>
>try to talk them out of using it, but such requests now cannot be
>refused.
>
>        Naessen's frustration lies in not having approval for the
>medicinal's
>use in the early or precancerous stages of the disease, where he thinks
>it might be of the most use.  But even with terminal patients he has
>begun receiving reports indicating that 714-X helps relieve pain and
>restore energy during a patient's final days or weeks.
>
>        As far as his troubles with the Quebec medical authorities go,
>they've
>resulted in a temporary draw.  Naessens and his lawyer, Conrad
>Chapdelaine, decided to fight back against the eighty-two counts that
>were laid after his first trial.
>
>        They countersued, issuing subpoenas to Augustin Roy, among
>others.  The
>medical college replied with a plea-bargain offer, and in the end
>dropped seventy-two of the counts and reduced Naessen's fine to $5,000.
>Naessens and his lawyer regarded the outcome as a technical victory, and
>
>so far there have been no more initiatives on the part of the
>authorities.
>
>        There is also growing interest in Naessen's approach to AIDS; he
>was
>invited to the controversial conference on alternative treatments held
>in Amsterdam last May - also attended by Luc Montagnier, the French
>scientist credited with discovery of HIV.
>
>        In Europe, the Philippines, New Zealand, and Australia,
>physicians are
>using 714-X, and researchers, covertly and overtly, are investigating
>his work.  Daily, results come in - favorable and unfavorable - the
>conclusion being that 714-X does work most effectively when the immune
>system has not been totally wrecked by disease.
>
>        This has always been Naessens's contention.  And as the new
>biology and
>the new medicine emerge, the textbooks will be rewritten, as they always
>
>have been, this time the emphasis shifting from cure to prevention.
>
>        An eminent Canadian oncologist (whom I will do the courtesy of
>not
>naming) has recently agreed, after visiting Rock Forest at my
>suggestion, to supervise certain tests to validate Naessens's somatid
>theory, an action that could jeopardize his career if publicized.
>
>        In the U.S., and independent study on 714-X using human
>patients,
>sponsored by Charles Pixley, from Rochester, N.Y., has been under way
>since January of 1992.
>
>        In the Eastern Townships the man who may well be recognized one
>day as
>a Galileo or an Einstein continues the work he has devoted half a
>century to, seemingly unconcerned by the fuss, the orthodox hostility.
>He works in silence and concentration in his laboratory, its windows on
>the Magog showing a landscape scarcely changed since the glaciers
>retreated.
>
>        Others have begun to praise him, but he himself might be content
>to
>live by a line from Paracelsus: "I pleased nobody except the people I
>cured."
>
>        This article originally appeared in  SATURDAY night, Canada's
>Magazine,
>(which has a circulation of 3,500,000) , published in Toronto, Ontario,
>December 1992 issue.
>
>        Paul William Roberts, an author and freelance journalist from
>Toronto,
>received the Canadian "Journalist of the Year" award for this article.
>
>Writers and Research, Inc.
>c/o general delivery at:
>4810 Saint Paul Boulevard
>Rochester, [zip code exempt]
>NEW YORK STATE
>
>Phone 716 544 2288
>Fax 716 544 1838
>E-mail pix108@frontiernet.net
>
>
>

========================================================================
Paul Andrew Mitchell                 : Counselor at Law, federal witness
B.A., Political Science, UCLA;  M.S., Public Administration, U.C. Irvine

tel:     (520) 320-1514: machine; fax: (520) 320-1256: 24-hour/day-night
email:   [address in tool bar]       : using Eudora Pro 3.0.3 on 586 CPU
website: http://www.supremelaw.com   : visit the Supreme Law Library now
ship to: c/o 2509 N. Campbell, #1776 : this is free speech,  at its best
             Tucson, Arizona state   : state zone,  not the federal zone
             Postal Zone 85719/tdc   : USPS delays first class  w/o this

As agents of the Most High, we came here to establish justice.  We shall
not leave, until our mission is accomplished and justice reigns eternal.
========================================================================
[This text formatted on-screen in Courier 11, non-proportional spacing.]

      


Return to Table of Contents for

Supreme Law School:   E-mail